Tivantinib in Treating Patients With Metastatic Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This randomized phase II trial studies how well tivantinib works compared to placebo in treating patients with metastatic prostate cancer. Tivantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Epistemonikos ID: 73d31816420f67f6161a521122110ba1c15b4599
First added on: May 10, 2024